XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Adoption of accounting pronouncement
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Adoption of accounting pronouncement
Balance at beginning of period at Dec. 31, 2019 $ 1,143,683 $ (558) $ 115 $ 1,127,487 $ (19,986) $ 36,067 $ (558)
Balance at beginning of period (in shares) at Dec. 31, 2019     115,120        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 89,915         89,915  
Other comprehensive income (loss) (13,700)       (13,700)    
Dividends declared (39,441)         (39,441)  
Net issuances of restricted stock 0   $ 1 (1)      
Net issuances of restricted stock (in shares)     745        
Stock-based compensation 13,525     13,525      
Repurchases of common stock (63,499)   $ (1)     (63,498)  
Repurchases of common stock (in shares)     (1,263)        
Balance at end of period at Mar. 31, 2020 $ 1,129,925   $ 115 1,141,011 (33,686) 22,485  
Balance at end of period (in shares) at Mar. 31, 2020     114,602        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cash dividends, per share (in usd per share) $ 0.34            
Balance at beginning of period at Dec. 31, 2019 $ 1,143,683 $ (558) $ 115 1,127,487 (19,986) 36,067 $ (558)
Balance at beginning of period (in shares) at Dec. 31, 2019     115,120        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 136,111            
Other comprehensive income (loss) (7,166)            
Balance at end of period at Jun. 30, 2020 1,156,706   $ 115 1,154,046 (27,152) 29,697  
Balance at end of period (in shares) at Jun. 30, 2020     114,635        
Balance at beginning of period at Mar. 31, 2020 1,129,925   $ 115 1,141,011 (33,686) 22,485  
Balance at beginning of period (in shares) at Mar. 31, 2020     114,602        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 46,196         46,196  
Other comprehensive income (loss) 6,534       6,534    
Dividends declared (38,975)         (38,975)  
Net issuances of restricted stock (in shares)     33        
Stock-based compensation 13,035     13,035      
Repurchases of common stock (9)   $ 0     (9)  
Repurchases of common stock (in shares)     0        
Balance at end of period at Jun. 30, 2020 $ 1,156,706   $ 115 1,154,046 (27,152) 29,697  
Balance at end of period (in shares) at Jun. 30, 2020     114,635        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cash dividends, per share (in usd per share) $ 0.34            
Balance at beginning of period at Dec. 31, 2020 $ 1,205,289   $ 113 1,179,972 (4,732) 29,936  
Balance at beginning of period (in shares) at Dec. 31, 2020     113,128        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 110,598         110,598  
Other comprehensive income (loss) (8,797)       (8,797)    
Dividends declared (43,300)         (43,300)  
Net issuances of restricted stock 0   $ 1 (1)      
Net issuances of restricted stock (in shares)     602        
Stock-based compensation 14,182     14,182      
Repurchases of common stock (80,273)   $ (1)     (80,272)  
Repurchases of common stock (in shares)     (1,048)        
Balance at end of period at Mar. 31, 2021 $ 1,197,699   $ 113 1,194,153 (13,529) 16,962  
Balance at end of period (in shares) at Mar. 31, 2021     112,682        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cash dividends, per share (in usd per share) $ 0.38            
Balance at beginning of period at Dec. 31, 2020 $ 1,205,289   $ 113 1,179,972 (4,732) 29,936  
Balance at beginning of period (in shares) at Dec. 31, 2020     113,128        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 259,811            
Other comprehensive income (loss) (4,360)            
Balance at end of period at Jun. 30, 2021 1,259,250   $ 112 1,208,056 (9,092) 60,174  
Balance at end of period (in shares) at Jun. 30, 2021     111,970        
Balance at beginning of period at Mar. 31, 2021 1,197,699   $ 113 1,194,153 (13,529) 16,962  
Balance at beginning of period (in shares) at Mar. 31, 2021     112,682        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 149,213         149,213  
Other comprehensive income (loss) 4,437       4,437    
Dividends declared (42,720)         (42,720)  
Net issuances of restricted stock (in shares)     5        
Stock-based compensation 13,903     13,903      
Repurchases of common stock (63,282)   $ (1)     (63,281)  
Repurchases of common stock (in shares)     (717)        
Balance at end of period at Jun. 30, 2021 $ 1,259,250   $ 112 $ 1,208,056 $ (9,092) $ 60,174  
Balance at end of period (in shares) at Jun. 30, 2021     111,970        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cash dividends, per share (in usd per share) $ 0.38